Oppenheimer Maintains Outperform on HCA Healthcare, Lowers Price Target to $485

Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $520 to $485.